Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cancer-Docetaxel'

Cancer-Docetaxel published presentations and documents on DocSlides.

Docetaxel 100 Mg M2
Docetaxel 100 Mg M2
by stefany-barnette
docetaxel price usa. docetaxel injection ip monog...
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
by ceila
Jeanny B. Aragon-Ching, M.D., F.A.C.P.. Clinical P...
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
by finley
Università . di Napoli “Federico II”. Innovat...
Second line treatments in WT
Second line treatments in WT
by deena
pts. : . which. . opportunities. with . biologic...
Thomas E. Keane Medical University of South Carolina
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Thomas E. Keane
Thomas E. Keane
by danika-pritchard
Medical University of South Carolina . Charleston...
Second line
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by cheryl-pisano
Moderator. Neil Love, MD. A Oliver Sartor, MD. Vi...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
L’algoritmo terapeutico
L’algoritmo terapeutico
by calandra-battersby
attraverso . i . c. asi clinici. Giuseppe . Valma...
Module 6: Prostate Cancer
Module 6: Prostate Cancer
by payton
Victoria . Sinibaldi. , RN, MS, CS, CANP, BC. Dani...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
treating early breast cancer
treating early breast cancer
by calandra-battersby
Debbie Bajrovic. Oncology Pharmacist. Mount Hospi...
Please note, these are the actual video-recorded proceedings from the live CME event and may includ
Please note, these are the actual video-recorded proceedings from the live CME event and may includ
by roxanne
Moderator. Neil Love, MD. A Oliver Sartor, MD. Vic...
Best practice for chemotherapy for treatment of breast cancer
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
by debby-jeon
Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...
What is the reference cytotoxic
What is the reference cytotoxic
by pasty-toler
regimen in advanced gastric cancer?. Florian Lor...
Novel Biologic Therapies for
Novel Biologic Therapies for
by olivia-moreira
Second-Line Gastric Cancer. Charles S. Fuchs, MD....
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
6th Annual Interdisciplinary
6th Annual Interdisciplinary
by giovanna-bartolotta
Prostate Cancer . Congress. Meeting in . a. Box....
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
Inequalities Access Cancer Types Treatment Variation Cancer Cancer
Inequalities Access Cancer Types Treatment Variation Cancer Cancer
by demetrius348
1. Access and treatment for cancer outline . 2. Ca...
Cancer treatment induced bone loss in breast cancer and prostate cancer: 2023 update
Cancer treatment induced bone loss in breast cancer and prostate cancer: 2023 update
by blanko
Azeez Farooki, MD. Attending Physician, Clinical M...
Cancer Patient organisation involvement in cancer policy and EU cancer Plan priorities
Cancer Patient organisation involvement in cancer policy and EU cancer Plan priorities
by isabella2
Charis Girvalaki. ECPC Director. European Cancer P...
Male breast cancer Meyskens Jr and Janaes Cancer Section Cancer Ins
Male breast cancer Meyskens Jr and Janaes Cancer Section Cancer Ins
by violet
L. MEYSKENS, D. (32, 33), and hormonal (42, 46, (6...
Breast Cancer Cancer : cancer is not just one disease but rather a
Breast Cancer Cancer : cancer is not just one disease but rather a
by SunkissedBabe
group. of diseases. . All forms of cancer cause c...
Pancreatic cancer is the 5th leading cause of death from cancer and the 11th most common cancer in
Pancreatic cancer is the 5th leading cause of death from cancer and the 11th most common cancer in
by WatercolorWanderlust
.. GREEK ORTHODOX LADIES PHILOPTOCHOS SOCIETY, INC...
Community Cancer Clusters Monica Brown, PhD Cancer Epidemiologist, the California Cancer Registry
Community Cancer Clusters Monica Brown, PhD Cancer Epidemiologist, the California Cancer Registry
by jane-oiler
Community Cancer Clusters Monica Brown, PhD Cance...
Lung Cancer Prevention and Early Detection Lung cancer is the second most common cancer in both men and women not counting skin cancer and is by far the leading cause of cancer death among both men an
Lung Cancer Prevention and Early Detection Lung cancer is the second most common cancer in both men and women not counting skin cancer and is by far the leading cause of cancer death among both men an
by luanne-stotts
Each year more people die of lung cancer than of ...
Pancreatic Cancer What is pancreatic cancer? Cancer starts when cells
Pancreatic Cancer What is pancreatic cancer? Cancer starts when cells
by natalia-silvester
What Is Cancer? Pancreatic cancer begins when cell...
Paradigm Shift in the Management of Metastatic Castration-Sensitive Prostate Cance
Paradigm Shift in the Management of Metastatic Castration-Sensitive Prostate Cance
by luna
m. CSPC). 1. Neal Shore, MD, FACS. Carolina Urolog...
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
by christina
Marsden internal audit – FN 35% with FEC-T (19. ...
Matthew D. Galsky, MD Director, GU Medical Oncology
Matthew D. Galsky, MD Director, GU Medical Oncology
by luanne-stotts
Tisch. Cancer Institute. Icahn School of Medicin...
ID DB06366 CATEGORY
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
New Ways of Managing Prostate Cancer
New Ways of Managing Prostate Cancer
by olivia-moreira
Jahangeer . M.Malik. Consultant Clinical Oncology...
Scientific Walter Cancer Detection Consortium Pancreatic Cancer
Scientific Walter Cancer Detection Consortium Pancreatic Cancer
by avery
March 7, 2018. Walter Park, MD, MS. On behalf of P...
Difference Cancer Classifier Determine Cancer Genetic Alterations
Difference Cancer Classifier Determine Cancer Genetic Alterations
by nolan
ngs. ) of biopsy specimen. Molecular Cancer Classi...
Cancer Screening Update Cancer Screening Breast Screening Program
Cancer Screening Update Cancer Screening Breast Screening Program
by nathan154
1. Cancer Screening Update IDCA MeetingSeptember 2...
Cancer Module The Cancer Module
Cancer Module The Cancer Module
by kimberly
. has 5 units. Each unit lasts about a week and co...
Cancer Stats Website Breast Cancer
Cancer Stats Website Breast Cancer
by mackenzie
SSG. 14. th. November 2018. https://cancerstats.n...